In 2015, HIV was the cause of 19 percent of all childhood deaths under the age of five in Lesotho. Previous strategies to identify and treat children who were living with HIV had proven ineffective and Lesotho’s goal to reach 80 percent of children living with HIV had...
As we welcome another World Hepatitis Day, the global response to eliminate viral hepatitis as a public threat is accelerating. Viral hepatitis, consisting of hepatitis B (HBV) and hepatitis C (HCV), affects more than 320 million people worldwide, with 90 percent of...
Amsterdam – A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries. Diagnostic testing improves patient care, helps prevent the...
We are delighted to announce the joint launch of a partnership to speed up development and introduction of optimized pediatric formulations of dolutegravir for children living with HIV in resource-limited settings. The new initiative includes an incentive program and...
In Vietnam, a million people are infected with Hepatitis C (HCV). Without treatment, HCV can cause cirrhosis, liver cancer and even death. While no vaccines exist to prevent HCV, the virus is easily treated with directly-acting antivirals (DAAs). In 2017, CHAI worked...